Read your latest personalised notifications
No account yet? Start here
Don't miss out
Ok, got it
Among CV diseases, coronary artery disease (CAD) is the single most common cause of health-related death in the EU. Early and accurate diagnosis in patients with symptoms suspected for stable CAD is deemed to be crucial to address effective treatment, to improve patient health status and ultimately to reduce the burden of disease.
Invasive coronary angiography (ICA) is the current gold standard for establishing the presence, location and severity of CAD, as well as for guiding revascularization procedures. However, the technique is costly, associated with a small intrinsic risk of morbidity and mortality and, may induce an excess of revascularizations with a potential negative impact on sanitary costs and patients outcome.
Significant improvements in non-invasive cardiovascular imaging (CVI) techniques and results from recent comparative effectiveness trials of imaging-guided strategies have driven increased interest to use non invasive CVI more routinely in the diagnostic algorithm for patients with suspected CAD even if inappropriate use may also drive escalating costs and potential risks.
The 2013 European Society of Cardiology (ESC) Guidelines for the management of stable CAD represented an important step forward providing specific recommendations on the use of non invasive imaging based on the best of available knowledge.
To which extent these Guidelines are applied in clinical practice, after 6 years from their release, is not known. In the meantime, new scientific evidence has been accumulated and either national Guidelines have been developed (ie. UK NICE Guidelines) and new ESC Guidelines will be issued in 2019. In current practice, the choice of non-invasive imaging tests in patients with symptoms suspected for stable CAD is also conditioned by multiple factors, such as national regulations, local expertise, preference, costs, test availability, etc.
EURECA Imaging registry is to assess the use of non-invasive cardiac imaging in a large, contemporary population of patients with stable symptoms, potentially caused by underlying CAD. The main purpose is to fill the gap in knowledge of real-world practice in this population. The factors conditioning adherence to Guidelines, local variability in the use of different modalities and possible effects on patient management and health status will be assessed. The results could be useful for the development process of the European Guidelines, and to promote strategies for improving quality of care and more efficient allocation of resources.
The study is centre based, with an Executive Committee and Scientific Committee. The two Chairpersons are Danilo Neglia and Victoria Delgado.
Danilo Neglia (Italy) – Registry ChairpersonVictoria Delgado (The Netherlands) – Registry Chairperson Alessia Gimelli (Italy)Bernard Cosyns (Belgium)Bogdan A. Popescu (Romania)Chiara Bucciarelli-Ducci (United Kingdom)Elif Sade (Turkey)Erwan Donal (France)Frank Flachskampf (Sweden)Gilbert Habib (France)Matteo Cameli (Italy)Maurizio Galderisi (Italy)Nuno Cardim (Portugal)Oliver Gaemperli (Switzerland)Steffen Petersen (United Kingdom)Stephan Achenbach (Germany) Thor Edvardsen (Norway)Aldo Maggioni (Italy), Scientific Coordinator for EORP
Alan Fraser (United Kingdom)Juhani Knuuti (Finland)Koen Nieman (USA)Leslee Shaw (USA) Rocco Friebel (United Kingdom)
The Scientific Committee (Members and Country Coordinators)Ahmed Al Jizeeri and Mouaz Al Mallah (Saudi Arabia, CC)Antti Saraste (Finland, CC)Arthur Scholte (The Netherlands, CC)Bernard Cosyns (Belgium, CC)Bogdan Popescu (Romania, CC)Constantinos Anagnostopoulus (Greece, CC)Daniele Andreini (Italy)Denisa Muraru and Alesia Gimelli (Italy, CC)Edyta Plonska-Gosciniak (Poland, CC)Eliana Reyes (United Kingdom, CC)Elif Sade (Turkey, CC)Filipe Macedo (Portugal, CC)Filipp Paleev (Russia, CC)Gianluca Pontone, (Italy)Gilles Barone-Rochette (France, CC)Henrik Engblom (Sweden, CC) Jelena Čelutkienė (Lithuania, CC)Jose’ Zamorano (Spain, CC)Julien Magne (France)Krasimira Hristova (Bulgaria, CC)Kyriakos Yiangou (Cyprus, CC)Marc Dweck (United Kingdom)Marcelo Haertel Miglioranza (Brazil, CC)Marian Gyongyosi and Senta Graf (Austria, CC)Mikko Pietila (Finland)Natallia Maroz-Vadalazhskaya (Belarus, CC)Pal Maurovich-Horvat (Hungary, CC)Patrizio Lancellotti (Belgium)Paul Knaapen (The Netherlands)Philipp Kaufmann (Switzerland)Riccardo Liga (Italy)Richard Underwood (United Kingdom)Ronny Buechel (Switzerland, CC)Slobodan Dodic (Serbia, CC)Stephan Achenbach (Germany, CC)Sven Plein (United Kingdom)Thor Edvardsen (Norway, CC)Tomaz Podlesnikar (Slovenia, CC)
Our mission: To reduce the burden of cardiovascular disease.
© 2020 European Society of Cardiology. All rights reserved.